Scientists track radioactive Drug's journey through cancer Patients' bones

NCT ID NCT04521361

Summary

This study aimed to understand how the radioactive drug Radium-223 moves through and collects in bones, particularly in areas without tumors, in men with advanced prostate cancer that has spread to bones. Researchers enrolled 46 men with different amounts of bone spread and gave them up to 6 injections of Radium-223 over several months. They used special scans to track exactly where the drug went in the body and bones after each dose.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Azienda USL IRCCS di Reggio Emilia_Arcispedale Santa Maria Nuova - S.C. Oncologia Provinciale

    Reggio Emilia, Emilia-Romagna, 42123, Italy

  • Guy's and St. Thomas' NHS Trust, St. Thomas' Hospital

    London, SE1 7EH, United Kingdom

  • HCL - Centre Hospitalier Lyon Sud

    Pierre-Bénite, 69495, France

  • ICM - Institut du Cancer de Montpellier - Val d'Aurelle

    Montpellier, 34298, France

  • Institut Claudius Regaud - iUCT Oncopole

    Toulouse, 31059, France

  • Institut de Cancerologie Ouest - Saint-Herblain

    Saint-Herblain, 44800, France

  • National Cancer Institute

    Vilnius, LT-08660, Lithuania

  • Rambam Health Corporation

    Haifa, 3109601, Israel

  • Royal Marsden NHS Trust (Surrey)

    Sutton, Surrey, SM2 5PT, United Kingdom

  • Uniklinikum Salzburg - Landeskrankenhaus

    Salzburg, 5020, Austria

  • University College London Hospitals NHS Foundation Trust

    London, NW1 2PG, United Kingdom

  • Vilnius University Hospital Santaros Klinikos

    Vilnius, LT-08661, Lithuania

Conditions

Explore the condition pages connected to this study.